ApprovalTrail

Approval · Notice of Compliance 3205 · 1998

SOLARASE: Notice of Compliance 3205

Issued May 20, 1998

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
3205
Date
May 20, 1998
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Other
Therapeutic class
Treatment of actinic keratoses

Products in this notice

BrandDINStatus today
SOLARASE02238019—

Medicinal ingredients